Identification of Chlamydia trachomatis CT621, a protein delivered through the type III secretion system to the host cell cytoplasm and nucleus

FEMS Immunology and Medical Microbiology

Volumn 57, Issue 1, 2009, Pages 46-58

  Hobolt Pedersen, Anne Sofie ^a   Christiansen, Gunna ^a   Timmerman, Evy ^b,c   Gevaert, Kris ^b,c   Birkelund, Svend ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

Chlamydia trachomatis; CT621 (CTL0885); Secretion; Subcellular proteome extraction; Two dimensional gel electrophoresis; Type III secretion

Indexed keywords

BACTERIAL PROTEIN; CT621 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; CYTOPLASM; FEMALE; HELA CELL; HOST CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN SECRETION; TYPE III SECRETION SYSTEM;

BACTERIAL PROTEINS; CELL NUCLEUS; CHLAMYDIA TRACHOMATIS; CYTOPLASM; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HELA CELLS; HUMANS; IMMUNOBLOTTING; MICROSCOPY, FLUORESCENCE; PROTEIN TRANSPORT; PROTEOME; STAINING AND LABELING; SULFUR RADIOISOTOPES; VIRULENCE FACTORS;

EID: 69949172392     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2009.00581.x     Document Type: Article

References (46)

1. Abdelrahman YM Belland RJ (2005) The chlamydial developmental cycle. FEMS Microbiol Rev 29 : 949 959.
2. Angot A, Vergunst A, Genin S Peeters N (2007) Exploitation of eukaryotic ubiquitin signaling pathways by effectors translocated by bacterial type III and type IV secretion systems. PLoS Pathog 3 : e3.
3. Bailey L, Gylfe A, Sundin C et al 2007) Small molecule inhibitors of type III secretion in Yersinia block the Chlamydia pneumoniae infection cycle. FEBS Lett 581 : 587 595.
4. Bavoil PM Hsia RC (1998) Type III secretion in Chlamydia: a case of deja vu? Mol Microbiol 28 : 860 862.
5. Belland RJ, Zhong G, Crane DD, Hogan D, Sturdevant D, Sharma J, Beatty WL Caldwell HD (2003) Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis. P Natl Acad Sci USA 100 : 8478 8483.
6. Birkelund S, Lundemose AG Christiansen G (1988) Chemical cross-linking of Chlamydia trachomatis. Infect Immun 56 : 654 659.
7. Bornberg-Bauer E, Rivals E Vingron M (1998) Computational approaches to identify leucine zippers. Nucleic Acids Res 26 : 2740 2746.
8. Chellas-Géry B, Linton CN Fields KA (2007) Human GCIP interacts with CT847, a novel Chlamydia trachomatis type III secretion substrate, and is degraded in a tissue-culture infection model. Cell Microbiol 9 : 2417 2430.
9. Chenna R, Sugawara H, Koike T, Lopez R, Gibson TJ, Higgins DG Thompson JD (2003) Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res 31 : 3497 3500.
10. Clifton DR, Fields KA, Grieshaber SS et al 2004) A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. P Natl Acad Sci USA 101 : 10166 10171.
11. Cornelis GR (2006) The type III secretion injectisome. Nat Rev Microbiol 4 : 811 825.
12. Everett KD, Bush RM Andersen AA (1999) Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms. Int J Syst Bacteriol 49 : 415 440.
13. Feldman MF Cornelis GR (2003) The multitalented type III chaperones: all you can do with 15 kDa. FEMS Microbiol Lett 219 : 151 158.
14. Fields KA Hackstadt T (2000) Evidence for the secretion of Chlamydia trachomatis CopN by a type III secretion mechanism. Mol Microbiol 38 : 1048 1060.
15. Gregory WW, Gardner M, Byrne GI Moulder JW (1979) Arrays of hemispheric surface projections on Chlamydia psittaci and Chlamydia trachomatis observed by scanning electron microscopy. J Bacteriol 138 : 241 244.
16. Haraga A Miller SI (2003) A Salmonella enterica serovar typhimurium translocated leucine-rich repeat effector protein inhibits NF-kappa B-dependent gene expression. Infect Immun 71 : 4052 4058.
17. Higgins DG Sharp PM (1988) CLUSTAL: a package for performing multiple sequence alignment on a microcomputer. Gene 73 : 237 244.
18. Hobolt-Pedersen A, Christiansen G Birkelund S (2006) Development of a new method to discover secreted C. trachomatis proteins. Eleventh International Symposium on Human Chlamydial Infections (Chernesky M, Caldwell H, Christiansen G, Clarke IN, Kaltenboeck B, Knirsch C, Kuo C, Mahony J, Rank RG, Saikku P, Schachter J, Stamm WE, Stephens RS, Summersgill JT, Timms P Wyrick PB, eds). 237 240. Niagara-on-the-Lake, ON, Canada.
19. Hotson A, Chosed R, Shu H, Orth K Mudgett MB (2003) Xanthomonas type III effector XopD targets SUMO-conjugated proteins in planta. Mol Microbiol 50 : 377 389.
20. Hsia RC, Pannekoek Y, Ingerowski E Bavoil PM (1997) Type III secretion genes identify a putative virulence locus of Chlamydia. Mol Microbiol 25 : 351 359.
21. Hueck CJ (1998) Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol Mol Biol R 62 : 379 433.
22. Kubori T Galan JE (2003) Temporal regulation of Salmonella virulence effector function by proteasome-dependent protein degradation. Cell 115 : 333 342.
23. Kumar S, Tamura K Nei M (2004) MEGA3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 5 : 150 163.
24. Landschulz WH, Johnson PF McKnight SL (1988) The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science 240 : 1759 1764.
25. Matsumoto A (1982) Electron microscopic observations of surface projections on Chlamydia psittaci reticulate bodies. J Bacteriol 150 : 358 364.
26. Moulder JW (1991) Interaction of chlamydiae and host cells in vitro. Microbiol Rev 55 : 143 190.
27. Muschiol S, Bailey L, Gylfe A et al 2006) A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis. P Natl Acad Sci USA 103 : 14566 14571.
28. Muschiol S, Normark S, Henriques-Normark B Subtil A (2009) Small molecule inhibitors of the Yersinia type III secretion system impair the development of Chlamydia after entry into host cells. BMC Microbiol 9 : 75.
29. Mygind P, Christiansen G, Persson K Birkelund S (1998) Analysis of the humoral immune response to Chlamydia outer membrane protein 2. Clin Diagn Lab Immun 5 : 313 318. (Pubitemid 28246451)
30. Nichols BA, Setzer PY, Pang F Dawson CR (1985) New view of the surface projections of Chlamydia trachomatis. J Bacteriol 164 : 344 349.
31. Okuda J, Toyotome T, Kataoka N et al 2005) Shigella effector IpaH9.8 binds to a splicing factor U2AF(35) to modulate host immune responses. Biochem Bioph Res Co 333 : 531 539.
32. Peters J, Wilson DP, Myers G, Timms P Bavoil PM (2007) Type III secretion a la Chlamydia. Trends Microbiol 15 : 241 251.
33. Rice P, Longden I Bleasby A (2000) EMBOSS: the European molecular biology open software suite. Trends Genet 16 : 276 277.
34. Rockey DD, Scidmore MA, Bannantine JP Brown WJ (2002) Proteins in the chlamydial inclusion membrane. Microbes Infect 4 : 333 340.
35. Schachter J Wyrick PB (1994) Culture and isolation of Chlamydia trachomatis. Method Enzymol 236 : 377 390.
36. Shaw AC, Vandahl BB, Larsen MR et al 2002) Characterization of a secreted Chlamydia protease. Cell Microbiol 4 : 411 424.
37. Sisko JL, Spaeth K, Kumar Y Valdivia RH (2006) Multifunctional analysis of Chlamydia-specific genes in a yeast expression system. Mol Microbiol 60 : 51 66.
38. Skipp P, Robinson J, O'Connor CD Clarke IN (2005) Shotgun proteomic analysis of Chlamydia trachomatis. Proteomics 5 : 1558 1573.
39. Stucke VM, Timmerman E, Vandekerckhove J, Gevaert K Hall A (2007) The MAGUK protein MPP7 binds to the polarity protein hDlg1 and facilitates epithelial tight junction formation. Mol Biol Cell 18 : 1744 1755.
40. Subtil A, Parsot C Dautry-Varsat A (2001) Secretion of predicted Inc proteins of Chlamydia pneumoniae by a heterologous type III machinery. Mol Microbiol 39 : 792 800.
41. Subtil A, Delevoye C, Balana ME, Tastevin L, Perrinet S Dautry-Varsat A (2005) A directed screen for chlamydial proteins secreted by a type III mechanism identifies a translocated protein and numerous other new candidates. Mol Microbiol 56 : 1636 1647.
42. Vandahl BB, Birkelund S, Demol H, Hoorelbeke B, Christiansen G, Vandekerckhove J Gevaert K (2001) Proteome analysis of the Chlamydia pneumoniae elementary body. Electrophoresis 22 : 1204 1223.
43. Vandahl BB, Stensballe A, Roepstorff P, Christiansen G Birkelund S (2005) Secretion of Cpn0796 from Chlamydia pneumoniae into the host cell cytoplasm by an autotransporter mechanism. Cell Microbiol 7 : 825 836.
44. Wolf K, Betts HJ, Chellas-Gery B, Hower S, Linton CN Fields KA (2006) Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle. Mol Microbiol 61 : 1543 1555.
45. Zhong G, Fan P, Ji H, Dong F Huang Y (2001) Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J Exp Med 193 : 935 942.
46. Zurawski DV, Mitsuhata C, Mumy KL, McCormick BA Maurelli AT (2006) OspF and OspC1 are Shigella flexneri type III secretion system effectors that are required for postinvasion aspects of virulence. Infect Immun 74 : 5964 5976.